Hunting the Nightmare Bacteria

October 22, 2013

FRONTLINE investigates the rise of deadly drug-resistant bacteria.

(54:11) FRONTLINE investigates the rise of deadly drug-resistant bacteria.

FEATURED FROM THIS REPORT

THE LATEST

WHO: Drug-Resistant Bugs Have Spread to “Alarming Levels”

A drug-resistant world “is instead a very real possibility for the 21st century,” according to a new report.

Florida Bill Would Combat Superbug Threat

A bill to track drug-resistant infections has been introduced in Florida, inspired in part by FRONTLINE’s “Hunting the Nightmare Bacteria.”

CDC: Some Doctors Contribute to Superbug Spread

Misusing antibiotics is one way to create more drug-resistant bacteria. Your doctor could be part of the problem.

Illinois “Nightmare Bacteria” Outbreak Raises Alarms

The largest outbreak on record of one so-called “nightmare bacteria” is fueling alarm among public health officials about the spread of potentially lethal drug-resistant infections.

Do Hospital Workers Really Wash Their Hands?

One hospital sent around a “secret shopper” to find out.

On John Quinn

The veteran drug researcher featured in “Hunting the Nightmare Bacteria” passed away last weekend.

Can the “Nightmare Bacteria” Be Stopped? – Live Chat Wed. 12 p.m. ET

Join a live chat on “Hunting the Nightmare Bacteria” with producer Rick Young, correspondent David Hoffman, infectious disease expert Dr. Sean Elliot, and guest questioner Maggie Koerth-Baker from BoingBoing. You can leave a question now.

Who’s Tracking the “Nightmare Bacteria”?

It seems like a basic question: How many people get these hard to treat infections each year and where do they occur? But there’s no easy answer.

Who’s Trying to Fix the Pipeline Problem?

The problem is clear: there aren’t enough new antibiotics. The question is why aren’t more pharmaceutical companies filling the gap — and what’s being done to try to reverse this trend?

Dr. Charles Knirsch: “These Are Not Ruthless Decisions”

The Pfizer executive on why the company has shifted away from developing antibiotics.

Dr. John Rex: The Drug Pipeline Is “Very, Very Thin”

The AstraZeneca executive on the business of antibiotics, and what his company is doing to address the lack of drugs in the pipeline.

Dr. Arjun Srinivasan: We’ve Reached “The End of Antibiotics, Period”

The CDC doctor says we need to create a new model to fight drug resistance, joining public and private funding with leadership at local levels.

Ramanan Laxminarayan: The Global Reach of Resistance

The policy chief on why the U.S. lags behind other nations in the race against this worldwide problem.

Dr. Brad Spellberg: Antibiotic Resistance Is “Everyone’s Fault”

The infectious disease expert says antibiotics have made us complacent about this threat.

Read More About the “Nightmare Bacteria”

Further resources on the superbug problem, and what we are — or aren’t — doing to stop it.

Additional funding for Hunting the Nightmare Bacteria is provided by The Kendeda Fund.

RELATED PROGRAMS

1:23:41TB Silent Killer03/25/2014
53:42Alaska Gold07/24/2012
blog comments powered by Disqus
SUPPORT PROVIDED BY

RECENT STORIES

FRONTLINE on

ShopPBS
Frontline Journalism Fund

Supporting Investigative Reporting

Funding for FRONTLINE is provided through the support of PBS viewers and by the Corporation for Public Broadcasting. Major funding for FRONTLINE is provided by The John D. and Catherine T. MacArthur Foundation. Additional funding is provided by the Park Foundation, the Wyncote Foundation, and the FRONTLINE Journalism Fund with major support from Jon and Jo Ann Hagler on behalf of the Jon L. Hagler Foundation.PBSPark FoundationMacArthur FoundationwyncoteCPB

FRONTLINE   Watch FRONTLINE   About FRONTLINE   Contact FRONTLINE
Privacy Policy   Journalistic Guidelines   PBS Privacy Policy   PBS Terms of Use   Corporate Sponsorship
FRONTLINE is a registered trademark of WGBH Educational Foundation.
Web Site Copyright ©1995-2014 WGBH Educational Foundation
PBS is a 501(c)(3) not-for-profit organization.